By Nick Malinowski ( July 12, 2010, 6:49 PM EDT) -- Apotex Corp. is the latest to set its sights on making a generic version of Cephalon Inc.'s narcolepsy and sleep apnea drug Nuvigil, alerting Cephalon that it is seeking regulatory approval for a new version of the drug and has challenged the validity of three patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.